Background illustration for clinical trials search

Paid Clinical Trials San Francisco

Discover 2,226 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

for
Overactive Bladder (OAB), Urinary Urgency,
Location: Palo Alto CA, Dallas TX, Madison WI, Chicago IL,
Sponsor: Medstar Health Research Institute

Sex: Female

Age: 22+

Code: NCT06797245

Recruiting

Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss

for
Sensorineural Hearing Loss, Bilateral
Location: San Francisco CA, Iowa City IA, Nashville TN,
Sponsor: Akouos, Inc.

Sex: All

Age: 0+

Code: NCT05821959

Phase1, Phase2, Recruiting

Child and Adolescent Registry for Participants With Narcolepsy

for
Narcolepsy
Location: Redwood City CA, San Diego CA, Tucson AZ,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 0 - 17

Code: NCT04899947

Recruiting

STRIDE Biorepository

for
Anemia, Sickle Cell
Location: Oakland CA, Oklahoma City OK, Houston TX, Iowa City IA,
Sponsor: Emory University

Sex: All

Age: 15 - 40

Code: NCT02843347

Recruiting

Effect of Fetal Aortic Valvuloplasty on Outcomes

for
Congenital Heart Disease, Aortic Valve Stenosis,
Location: San Francisco CA, Columbus OH, Toronto
Sponsor: Queen Silvia Children's Hospital, Gothenburg, Sweden

Sex: All

Age: 0

Code: NCT05386173

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: San Francisco CA, Oakland CA, Sacramento CA, Madera CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 6 - 39

Code: NCT05702645

Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: San Francisco CA, Oakland CA, Madera CA, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase2, Recruiting

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

for
Degenerative Disc Disease, Disc Degeneration,
Location: Napa CA, Reno NV, Santa Monica CA, Eugene OR,
Sponsor: VIVEX Biologics, Inc.

Sex: All

Age: 22 - 70+

Code: NCT06778447

Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: San Francisco CA, Palo Alto CA, Woodland CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase2, Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

for
Renal Cell Carcinoma
Location: San Francisco CA, Nashville TN, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07049926

Phase1, Phase2, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: San Francisco CA, Sacramento CA, West Hills CA,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase3, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin

for
Squamous Cell Carcinoma
Location: Redwood City CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06731933

Phase2, Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Lafayette CA, Santa Rosa CA, Oxnard CA, Lancaster CA,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase1, Phase2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

for
Malignant Melanoma
Location: San Francisco CA, Seattle WA, Springdale AR, Brampton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06961006

Phase2, Recruiting

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for
Malignant Glioma
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 21

Code: NCT05099003

Phase1, Phase2, Recruiting

Opiate Use and Biliary Dilation

for
Evaluation of Association Between Opiate Use and Biliary Dilation,
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 0+

Code: NCT03870347

Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: San Francisco CA, Walnut Creek CA, Santa Rosa CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase3, Recruiting